LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 50.36 | 84.90 | 4913 | 5651 | 0.8694 | 0.9543 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 52.06 | 84.90 | 702 | 5990 | 0.1172 | 0.4106 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 52.06 | 84.90 | 4153 | 5990 | 0.6932 | 0.8842 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 52.06 | 84.90 | 449 | 5990 | 0.0749 | 0.3116 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 52.06 | 84.90 | 5140 | 5990 | 0.8580 | 0.9507 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 53.77 | 84.90 | 820 | 6252 | 0.1311 | 0.4414 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 53.77 | 84.90 | 4404 | 6252 | 0.7043 | 0.8901 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 53.77 | 84.90 | 489 | 6252 | 0.0782 | 0.3262 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 53.77 | 84.90 | 5473 | 6252 | 0.8753 | 0.9575 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 55.48 | 84.90 | 885 | 6567 | 0.1348 | 0.4530 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 55.48 | 84.90 | 4607 | 6567 | 0.7015 | 0.8901 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 55.48 | 84.90 | 465 | 6567 | 0.0708 | 0.3114 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 55.48 | 84.90 | 5769 | 6567 | 0.8784 | 0.9591 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 57.18 | 84.90 | 960 | 6963 | 0.1379 | 0.4645 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 57.18 | 84.90 | 4820 | 6963 | 0.6922 | 0.8876 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 57.18 | 84.90 | 529 | 6963 | 0.0760 | 0.3334 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 57.18 | 84.90 | 6082 | 6963 | 0.8734 | 0.9579 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 58.88 | 84.90 | 1012 | 7291 | 0.1388 | 0.4707 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 58.88 | 84.90 | 5086 | 7291 | 0.6975 | 0.8909 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 58.88 | 84.90 | 526 | 7291 | 0.0721 | 0.3283 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 58.88 | 84.90 | 6296 | 7291 | 0.8634 | 0.9548 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 60.59 | 84.90 | 1031 | 7641 | 0.1349 | 0.4690 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 60.59 | 84.90 | 5253 | 7641 | 0.6874 | 0.8878 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 60.59 | 84.90 | 588 | 7641 | 0.0769 | 0.3473 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 60.59 | 84.90 | 6566 | 7641 | 0.8592 | 0.9538 | MN20160318_Q02 | E21 |